Multiple studies have reported inhibition of cell proliferation and/or cell cycle progression in breast cancer cell lines upon pharmacological PDI-inhibition or PDIA3 silencing (121, 122, 128, 133). The gene discussed is PDIA3; the disease is breast carcinoma.